Passage Bio Inc

NASDAQ:PASG   1:02:14 PM EDT
2.05
-0.01 (-0.48%)
Earnings Announcements

Passage Bio Q2 Loss Per Share $0.73

Published: 08/04/2022 12:01 GMT
Passage Bio Inc (PASG) - Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights.
Q2 Loss per Share $0.73.
Ended 2q22 With Strong Cash Position; Cash on Hand to Fund Operations Into 2q24.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.80

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.78

More details on our Analysts Page.